LSA
ELTX icon

Leonteq Securities AG’s Elicio Therapeutics ELTX Stock Holding History

Leonteq Securities AG’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.2K Buy
+20,000
New +$201K ﹤0.01% 724

Other funds holding ELTX

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
MHC
Meyer Handelman Company Rye Brook, New York $3.53B AUM 30.49% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Leonteq Securities AG's ELTX Position: Q2 2026 in Review

Leonteq Securities AG opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 20,000 shares worth $78.2K. The stake represents ﹤0.01% of the portfolio and ranks #724 among its holdings.

11 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Leonteq Securities AG held 20,000 shares of Elicio Therapeutics worth $78.2K as of Q2 2026.
  • Elicio Therapeutics was a new Leonteq Securities AG position in Q2 2026.
  • Elicio Therapeutics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #724 holding.
  • 11 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.